IRENAT

This brand name is authorized in Estonia.

Active ingredients

The drug IRENAT contains one active pharmaceutical ingredient (API):

1	Sodium perchlorate UNII 97F4MTY3VA - SODIUM PERCHLORATE
	Perchlorate competitively inhibits the thyroid’s iodine uptake mechanism, iodination and affects iodisation by flushing the thyroid of iodide that is accumulating but has not yet been incorporated into a thyroglobulin molecule. Re-utilisation of iodide released outside the thyroid during deiodination of thyroid hormone is also inhibited. The antithyroid effect is based on the occurrence of iodine depletion.
	Read more about Sodium perchlorate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
IRENAT Oral drops	MPI, EU: SmPC	Base de données publique des médicaments (FR)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H03BC01	Potassium perchlorate	H Systemic hormonal preparations, excl. Sex hormones and insulins → H03 Thyroid therapy → H03B Antithyroid preparations → H03BC Perchlorates
Discover more medicines within H03BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1803372